ArticleVirology2025
A targeted genetic screen identifies Caenorhabditis elegans genes involved in RNAi-independent antiviral defense.
Article in Virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Characterizing the role of RSD-6 in the biogenesis of virus-derived small interfering RNAs and the modulation of viral pathogenesis.Journal of virology · 2026Article
- Beyond Pathogenesis: The Nematode Immune Network as the Arbiter of a Host-Virus Truce.Viruses · 2025Review
- Characterizing the role of RSD-6 in the biogenesis of virus-derived small interfering RNAs and the modulation of viral pathogenesis.bioRxiv : the preprint server for biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Cellular organisms are constantly challenged by potentially lethal viral infections and rely on diverse antiviral mechanisms for survival. In several systems, including plants and insects, parallel antiviral pathways provide redundancy, ensuring host protection even if one pathway is compromised by a virus. However, whether such alternative antiviral mechanisms exist in nematodes beyond RNA interference (RNAi) remains largely unexplored. To address this question and as proof of principle, we conducted a small-scale genetic screen to identify C. elegans genes involved in RNAi-independent antiviral defense (RiAD). The reporter system for this screen was a combination of a GFP-tagged flock house virus replicon, as the readout of efficient viral replication, and an RNAi-deficient triple mutant. The reporter C. elegans strain also carried a recessive E3 allele, which suppresses the replication of both flock house virus and Orsay virus. Because this reporter strain lacks a functional RNAi response, any restoration of viral replication in the screen is unlikely due to RNAi disruption, thereby enriching for mutants with defects in RiAD. Upon completing this biased genetic screen we identified ten recessive alleles which were assigned to eight candidate genes. Notably, five of these genes also contributed to RiAD against Orsay virus, indicating a role in broad-spectrum natural antiviral defense. Strikingly, removal of the E3 allele in one of the mutant backgrounds resulted in lethal Orsay virus infection, suggesting that RiAD plays a critical role in protecting C. elegans from fatal viral infection in the absence of RNAi under natural conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.